EUROPEAN JOURNAL OF THERAPEUTICS, vol.27, no.2, pp.149-157, 2021 (ESCI)
Article / Article
EUROPEAN JOURNAL OF THERAPEUTICS
Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
Drug eluting stent, everolimus, coronary artery disease, ANTIPLATELET THERAPY, CLINICAL-EVALUATION, FOLLOW-UP, OUTCOMES, DISEASE, HYPERTENSION, PREVALENCE, AWARENESS, APPROVAL, TURKEY
Hacettepe University Affiliated:
Objective: Drug eluting stents have become an important component in percutaneous treatment of patients with symptomatic coronary artery disease. The population in the previous drug eluting stent studies has very risk profile, and therefore not reflects real-world information. Moreover, there are limited data to evaluate risk factors and predictors of intended outcomes. In this study, everolimus eluting stent (XIENCE V) implantations and follow-up results in patients with coronary artery disease were evaluated.